[HTML][HTML] Antiviral and antimicrobial nucleoside derivatives: structural features and mechanisms of action
AA Zenchenko, MS Drenichev, IA Il'Icheva… - Molecular biology, 2021 - Springer
The emergence of new viruses and resistant strains of pathogenic microorganisms has
become a powerful stimulus in the search for new drugs. Nucleosides are a promising class …
become a powerful stimulus in the search for new drugs. Nucleosides are a promising class …
[图书][B] Chemical synthesis of nucleoside analogues
P Merino - 2013 - Wiley Online Library
Nucleosides are the building blocks required in constructing nucleic acids. As we learned in
school, billions of combinations are possible using only four different nucleosides, and thus …
school, billions of combinations are possible using only four different nucleosides, and thus …
[图书][B] Nucleoside analogues: chemistry, biology, and medical applications
RT Walker - 2012 - books.google.com
This publication contains the Review Lectures given at a joint NATO Advanced Study
Institute and a FEB S Advanced Study Course, held at Sogesta (Nr. Urbino), Italy from the …
Institute and a FEB S Advanced Study Course, held at Sogesta (Nr. Urbino), Italy from the …
Antiviral activity spectrum and target of action of different classes of nucleoside analogues
ED Clercq - Nucleosides, Nucleotides & Nucleic Acids, 1994 - Taylor & Francis
Depending on the target enzyme with which they interact, nucleoside analogues exhibit
marked differences in their antiviral activity spectrum. The activity spectrum of those …
marked differences in their antiviral activity spectrum. The activity spectrum of those …
[HTML][HTML] Antiviral nucleosides
TS Mansour, R Storer - Current Pharmaceutical Design, 1997 - books.google.com
This article provides an overview of the field of nucleoside antiviral agents in so far as they
have some level of current interest. It considers compounds in a number of structural …
have some level of current interest. It considers compounds in a number of structural …
Novel nucleoside strategies for anti-HIV and anti-HSV therapy
PAMM Herdewijn - Antiviral research, 1992 - Elsevier
This mini-review describes the structure-activity relationships of several series of new
nucleoside analogues. It also points to the possibilities of finding new molecular …
nucleoside analogues. It also points to the possibilities of finding new molecular …
The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold
MK Yates, KL Seley-Radtke - Antiviral research, 2019 - Elsevier
This is the second of two invited articles reviewing the development of nucleoside analogue
antiviral drugs, written for a target audience of virologists and other non-chemists, as well as …
antiviral drugs, written for a target audience of virologists and other non-chemists, as well as …
Nucleoside analogs: similarities and differences
JP Sommadossi - Clinical Infectious Diseases, 1993 - academic.oup.com
Among the steps in the replication cycle of human immunodeficiency virus (HIV) that are
potential targets for antiviral chemotherapy, the viral DNA polymerase or reverse …
potential targets for antiviral chemotherapy, the viral DNA polymerase or reverse …
Comments on nucleotide delivery forms
C Périgaud, JL Girardet, G Gosselin… - Advances in antiviral drug …, 1996 - Elsevier
Publisher Summary A multitude of factors affect the biological activity of nucleoside analogs
(Nu), which must be phosphorylated intracellularly by cellular or viral enzymes before …
(Nu), which must be phosphorylated intracellularly by cellular or viral enzymes before …
The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold
KL Seley-Radtke, MK Yates - Antiviral research, 2018 - Elsevier
This is the first of two invited articles reviewing the development of nucleoside-analogue
antiviral drugs, written for a target audience of virologists and other non-chemists, as well as …
antiviral drugs, written for a target audience of virologists and other non-chemists, as well as …